Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
14 June 2017
E-002348/2017
Answer given by Mr Andriukaitis on behalf of the Commission

The organisation of health systems and delivery of care are Member States' responsibility, including the measures in the area of use of medicines by patients.

The Commission is co-financing the ‘Simpathy’(1) project which aims at developing ways to improve the rational use of medicines in the context of multiple treatments (polypharmacy) and an action group under the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) (2) is focusing on adherence to treatment.

Regarding the safe use of medicines, the Commission has also funded several projects through its research programme. For example the ‘Monitoring Medicines’ project(3) in the area of medicine-related patient harm and consumer reporting of adverse events of medicines resulted in practical guidelines available at the World Health Organisation website(4).

There is currently a specific focus on projects developing and validating new digital solutions(5) which can contribute to healthy ageing, including on the issue of medications use.

EIP on AHA partners remain committed to the goal of increasing average healthy life years in Europe given the decline in the healthy life years expectancy registered between 2010 and 2014(6). Further measures to harness the potential of digital innovation to support better treatment, diagnosis and prevention of diseases, notably chronic diseases have been announced by the Commission in the context of the Digital Single Market mid-term review(7).

(1)http://www.simpathy.eu/
(2)https://ec.europa.eu/eip/ageing/action-groups-eip-aha/a1-adherence-prescription_en
(3)http://cordis.europa.eu/project/rcn/91861_en.html
(4)http://www.who.int/medicines/areas/quality_safety/safety_efficacy/qas_safetymonitoringmp/en/
(5)https://ec.europa.eu/digital-single-market/en/policies-ageing-well-ict
(6)The decline of healthy life years expectancy in all indicators: men, women, at birth and at 65 (EU28 averages in 2010 and 2014). http://ec.europa.eu/eurostat/statistics-explained/index.php/Healthy_life_years_statistics
(7)COM(2017) 228 final.

Last updated: 21 June 2017Legal notice